Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss

NCT02941445 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Polycystic Ovary Syndrome
Body Weight

Interventions

DRUG: sitagliptin and metformin
DRUG: Metformin

Sponsor

University Medical Centre Ljubljana